Literature DB >> 32755492

Interventions to improve spontaneous adverse drug reaction reporting by healthcare professionals and patients: systematic review and meta-analysis.

Vibhu Paudyal1, Abdullah Al-Hamid1, Matthew Bowen1, Muhammad Abdul Hadi1, Syed Shahzad Hasan2, Zahraa Jalal1, Derek Stewart3.   

Abstract

INTRODUCTION: The aim of this study was to evaluate the effectiveness of interventions used for improving ADR reporting by patients and healthcare professionals. AREAS COVERED: A systematic review of literature was conducted by searching Medline, Embase and Cochrane Central Register of Controlled of Trials. Meta-analysis of randomized controlled trials (RCTs; n = 5) was conducted to estimate the pooled risk ratio for the effectiveness of interventions on ADR reporting rates. Data from observational studies were synthesized using narrative synthesis approach. EXPERT OPINION: A total of 28 studies were included. All except one study targeted healthcare professionals using educational, technological, policy, financial and/or mixed interventions. The results showed that financial and face-to-face educational interventions improved quality and quantity of ADR reporting when compared with interventions not involving face-to-face interactions. However, the quality of studies was generally low. Meta-analysis showed a statistically significant 3.5-fold overall increase in reporting of ADRs [RR 3.53; 95% CI (1.77,7.06)] in the intervention group compared to the control. There was a lack of consideration of theory and sustainability in the design of the interventions. There is a need to develop and test theory-based interventions and target patient reporting. More research needs to be conducted in the low- and middle-income countries.

Entities:  

Keywords:  Adverse drug reactions; drug utilization; medication safety; pharmacovigilance

Mesh:

Year:  2020        PMID: 32755492     DOI: 10.1080/14740338.2020.1807003

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  6 in total

1.  Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study.

Authors:  Renly Lim; Christopher Thornton; Jan Stanek; Lisa Kalisch Ellett; Myra Thiessen
Journal:  JMIR Form Res       Date:  2022-10-07

2.  Why hospital-based healthcare professionals do not report adverse drug reactions: a mixed methods study using the Theoretical Domains Framework.

Authors:  Raymond Li; Kate Curtis; Connie Van; Syed Tabish Razi Zaidi; Chin Yen Yeo; Christina Arun Kali; Mithila Zaheen; Grace Therese Moujalli; Ronald Castelino
Journal:  Eur J Clin Pharmacol       Date:  2022-04-27       Impact factor: 3.064

3.  Cognitive deficits and memory impairments after COVID-19 (Covishield) vaccination.

Authors:  Bipin Chaurasia; Vishal Chavda; Bingwei Lu; Kanwaljeet Garg; Nicola Montemurro
Journal:  Brain Behav Immun Health       Date:  2022-04-23

4.  Attitudes of Undergraduate Nursing Students towards Patient Safety: A Quasi-Experimental Study.

Authors:  Nuria Cantero-López; Víctor M González-Chordá; María Jesús Valero-Chillerón; Desirée Mena-Tudela; Laura Andreu-Pejó; Rafael Vila-Candel; Águeda Cervera-Gasch
Journal:  Int J Environ Res Public Health       Date:  2021-02-03       Impact factor: 3.390

5.  Changes in suspected adverse drug reaction reporting via the yellow card scheme in Wales following the introduction of a National Reporting Indicator.

Authors:  Paul N Deslandes; Robert Bracchi; Karen Jones; Kath E Haines; Emma Carey; Alana Adams; Jenna Walker; Alison Thomas; Philip A Routledge
Journal:  Br J Clin Pharmacol       Date:  2022-04-07       Impact factor: 3.716

6.  Adverse events related to COVID-19 vaccines: the need to strengthen pharmacovigilance monitoring systems.

Authors:  Sunil Shrestha; Januka Khatri; Sujyoti Shakya; Krisha Danekhu; Asmita Priyadarshini Khatiwada; Ranjit Sah; Bhuvan Kc; Vibhu Paudyal; Saval Khanal; Alfonso J Rodriguez-Morales
Journal:  Drugs Ther Perspect       Date:  2021-08-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.